相关实验视频
Updated: Feb 20, 2026
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.3K
骨质疏松症管理的进展:一个案例系列
Maurizio Nordio1,2, Roberto Baldelli3,4
1Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. maurizionordio1@gmail.com.
Journal of medical case reports
|February 19, 2026
概括
新的补充剂,包括D-chiro-inositol和alpha-lactalbumin,在改善骨质疏松症患者的骨代谢方面表现有前途. 这些化合物与标准维生素一起,可以增强骨健康标志物.
科学领域:
- 骨代谢和内分泌学 骨代谢和内分泌学
- 营养生物化学 营养生物化学
背景情况:
- 骨质疏松症是一种骨矿物质密度降低的疾病,增加骨折风险,并可能导致骨质疏松症.
- 标准的骨质疏松症管理包括补充,维生素D和维生素K.
- 新兴研究表明,D-chiro-inositol和alpha-lactalbumin可能通过胰岛素敏感化和营养吸收有利于骨健康.
研究的目的:
- 为了研究联合补充剂治疗方案对骨质疏松患者骨代谢的影响.
- 评估D-chiro-inositol和alpha-lactalbumin作为骨质疏松症的辅助疗法的潜力.
主要方法:
- 一个为期2个月的每日,胆醇 (维生素D),维生素K2,D-chiro-inositol和alpha-lactalbumin的治疗方案被给予六名骨质疏松患者.
- 血清中维生素D,骨质素,性酸酶和副甲状腺激素的水平被监测.
- 在治疗期之前和之后评估了骨矿物质密度 (T-score).
主要成果:
- 没有观察到T分数的显著变化.
- 所有患者的血清维生素D水平都有所改善.
- 血清骨质卡尔辛水平增加,表明骨形成增强.
- 标志着性酸酶和副甲状腺激素水平的波动.
结论:
- 联合补充剂对骨代谢标志物产生了积极的影响,特别是维生素D和骨素水平.
- D-chiro-inositol和alpha-lactalbumin显示出作为骨质疏松症管理的治疗剂的潜力.
- 需要进一步的临床研究来阐明精确的分子机制和长期影响.
更多相关视频
03:56Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
1.3K
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
1.1K
相关概念视频
01:31Osteoclasts in Bone Remodeling
4.3K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.3K
01:25Role of Vitamins in Maintaining Bone Health
5.7K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.7K
01:29Bone Disorders
5.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.6K
01:40Bone Remodeling
40.6K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.6K
01:26Atherosclerosis III: Management
465
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
01:30Urinary Tract Calculi III: Medical Management
288
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
288